Dolutegravir/Lamivudine Is Noninferior to Continuing Dolutegravir- and Non-Dolutegravir-Based Triple-Drug Antiretroviral Therapy in Virologically Suppressed People With Human Immunodeficiency Virus: DUALING Prospective Nationwide Matched Cohort StudyOPEN FORUM INFECTIOUS DISEASESIF3.82024-03-180OAAI
Systematic Review: Strategies for Improving HIV Testing and Detection Rates in European HospitalsMICROORGANISMSIF4.22024-01-253OAAI
Vaccination against HBV and HAV as Mode of Hepatitis Prevention among People Living with HIV-Data from ECEE Network GroupVACCINESIF3.42023-05-145OAAI
PrEP Scale-Up and PEP in Central and Eastern Europe: Changes in Time and the Challenges We Face with No Expected HIV Vaccine in the near FutureVACCINESIF3.42023-01-048OAAI
National medical specialty guidelines of HIV indicator conditions in Europe lack adequate HIV testing recommendations: a systematic guideline reviewEUROSURVEILLANCEIF7.82022-12-019OAAI
Unified European support framework to sustain the HIV cascade of care for people living with HIV including in displaced populations of war-struck UkraineLANCET HIVIF132022-06-0139OAAI
The Presence of Either Typical or Atypical Radiological Changes Predicts Poor COVID-19 Outcomes in HIV-Positive Patients from a Multinational Observational Study: Data from Euroguidelines in Central and Eastern Europe Network GroupVIRUSES-BASELIF3.52022-05-056OAAI
Prospective evaluation of hepatitis C virus antibody detection in whole blood collected on dried blood spots with the INNOTEST? HCV Ab IV enzyme immunoassayJOURNAL OF CLINICAL VIROLOGYIF3.42021-04-014OAAI
Achievements and gaps to provide pre-exposure prophylaxis (PrEP) for women across the European Region - Results from a European survey studyJOURNAL OF VIRUS ERADICATIONIF22021-03-0112OAAI
Where is the greatest impact of uncontrolled HIV infection on AIDS and non-AIDS events in HIV?AIDSIF3.12018-01-146OAAI
MOBILE GYNECOLOGICAL CLINIC - EFFECTIVE TOOL FOR HIV\STI SCREENING DIAGNOSTICS FOR COMMERCIAL SEX WORKERS IN LVIV REGION (UKRAINE)SEXUALLY TRANSMITTED INFECTIONSIF2.92013-07-130OAAI